GOLM1 and hepatocellular carcinoma: Indeed, a recent study reveals that IFN-β activates GP73 expression and represses innate immune response in viral-infected HCC cells through facilitating the degradation of mitochondrial antivirus signaling protein (MAVS)/TNF receptor-associated factor 6 (TRAF6) and attenuating IFN-β promoter (63).